Administration of intravenous immunoglobulins for prophylaxis or treatment of infection in preterm infants: meta-analyses
- PMID: 7796228
- PMCID: PMC2528428
- DOI: 10.1136/fn.72.3.f151
Administration of intravenous immunoglobulins for prophylaxis or treatment of infection in preterm infants: meta-analyses
Abstract
Aims: To determine the effectiveness of intravenous immunoglobulin administration to premature infants in the prevention and/or treatment of bacterial infection.
Methods: Computer searches of MEDLINE, EMBASE, SCISEARCH and Oxford Database of Perinatal Trials were made. Two independent researchers applied inclusion criteria of: randomised controlled trial; premature and/or low birthweight infant; use of intravenous immunoglobulin; and infection or mortality. Nineteen of 44 identified studies fulfilled these criteria. Study quality was assessed and information on study population, intervention, and outcomes were collected.
Results: Studies were divided into prophylaxis or treatment; results were tabulated for infection, sepsis, and death from all causes. For 17 studies of prophylaxis (n = 5245), the relative risk and confidence interval were, for proved infection 0.81, 0.67-0.97; for sepsis 0.87, 0.66-1.13; for death from all causes 0.85, 0.64-1.14. Some outcome results were heterogeneous. Two treatment studies showed no reduction in mortality when combined.
Conclusions: Routine administration of intravenous immunoglobulin to preterm infants is not recommended.
Comment in
-
Pitfalls of meta-analysis.Arch Dis Child Fetal Neonatal Ed. 1995 Nov;73(3):F196. doi: 10.1136/fn.73.3.f196. Arch Dis Child Fetal Neonatal Ed. 1995. PMID: 8535882 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical